FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 299:285-289 August 10, 1978 Number 6 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

The Wernicke-Korsakoff syndrome is a thiamine-deficiency disorder occurring primarily among alcoholics. To determine the economic feasibility of preventing this disease by fortification of alcoholic beverages with thiamine, we compared the cost of fortification with the cost of institutionalizing alcoholics with the disorder. The estimated annual incidence of institutionalization is eight per million adult population. The cost of long-term institutionalization, discounted to present value, is $70 million per year. The cost of adequately fortifying alcoholic beverages is estimated to range from $3 million per year if allithiamines are used, to as much as $17 million per year if thiamine hydrochloride proves necessary. Thus, the cost-benefit ratio may range from 1:23 to 1:4. It is economically advantageous to prevent the Wernicke-Korsakoff syndrome by fortification of alcoholic beverages with thiamine. The stability, safety and marketability of thiamine and the allithiamines in alcoholic beverages should be studied further.

This article has been cited by other articles:

• THOMSON, A. D., MARSHALL, E. J. (2006). THE TREATMENT OF PATIENTS AT RISK OF DEVELOPING WERNICKE'S ENCEPHALOPATHY IN THE COMMUNITY. Alcohol Alcohol 41: 159-167 [Abstract] [Full Text]  
• Hoffman, R. S., Goldfrank, L. R. (1995). The Poisoned Patient With Altered Consciousness: Controversies in the Use of a 'Coma Cocktail'. JAMA 274: 562-569 [Abstract]  
• Udvarhelyi, I. S., Colditz, G. A., Rai, A., Epstein, A. M. (1992). Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature: Are the Methods Being Used Correctly?. ANN INTERN MED 116: 238-244 [Abstract]  
• Koprowski, C. D., Longstreth, W. T. Jr, Cebul, R. D. (1989). Clinical Neuroepidemiology: III. Decisions. Arch Neurol 46: 223-229 [Abstract]  
• KASSIRER, J. P., MOSKOWITZ, A. J., LAU, J., PAUKER, S. G. (1987). Decision Analysis: A Progress Report. ANN INTERN MED 106: 275-291 [Abstract]